ArticleDEN open2027
White Globe Appearance Is an Endoscopic Predictor of Metachronous Multiple Gastric Cancers.
Article in DEN open, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: White globe appearance (WGA) is a small white lesion with a globular shape identified during magnifying endoscopy with narrow-band imaging. However, the association between WGA and metachronous gastric cancer remains unclear. Methods: This study involved patients who underwent endoscopic submucosal dissection (ESD) for first-episode single gastric cancer at our institution between January 2012 and December 2018 and who had at least one endoscopic follow-up after resection. WGA-positive gastric cancer was defined by the presence of WGA, and metachronous gastric cancer was defined as new cancer arising at a different site ≥1 year after ESD. The primary endpoint was a comparison of the incidence of metachronous gastric cancers in patients with WGA-positive versus WGA-negative gastric cancer. Univariate and multivariate analyses were conducted using the following variables: WGA status, sex, age, and severe atrophy. Results: In total, 160 WGA-positive and 284 WGA-negative gastric cancer cases were included. Metachronous gastric cancers were significantly more frequent in the WGA-positive group ( Conclusions: WGA may be a predictive marker for metachronous gastric cancers. In cases of WGA-positive gastric cancer, endoscopic follow-up should be conducted with heightened attention to the risk of metachronous lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.